By proceeding, you agree to our Terms of Use and Privacy Policy.
Welcome to the 10th Annual Cholangiocarcinoma Foundation Conference. The three-day event, including a special Patient Day and two-day scientific meeting, features cutting-edge research, innovative therapies, and the latest education for cholangiocarcinoma patients, caregivers, and professionals. It is a pleasure to offer you an in-person and virtual experience. Being able to meet face-to-face amid safety precautions enriches the conference experience by uniting people who are fearlessly working to find a cure for cholangiocarcinoma. Enjoy Salt Lake City and experience a successful conference that features clinical and scientific updates, panel discussions, poster presentations, and more.
Learn about the latest advances in cholangiocarcinoma research and treatment.
Explore cutting-edge research, innovative therapies, and the latest education for cholangiocarcinoma patients, caregivers, and professionals.
Attendees will gain a deeper understanding of cholangiocarcinoma and its treatment options from top healthcare providers and industry experts.
Hear from top industry leaders, experts and professionals to gain deep knowledge on the latest cholangiocarcinoma treatment and research education.
The Cholangiocarcinoma Foundation is a 501(c)(3) non-profit organization. Its vision is to bring about a CURE for cholangiocarcinoma, more commonly known as bile-duct cancer, through Collaboration, Understanding, Research and Education.
At Boehringer Ingelheim we create value through innovation with one clear goal: to improve the lives of patients. We develop breakthrough therapies and innovative healthcare solutions in areas of unmet medical need for both humans and animals.
Incyte is a global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of novel medicines.
Relay Therapeutics is a clinical-stage precision medicines company transforming the drug discovery process.
Servier is a global pharmaceutical group governed by a Foundation. With a strong international presence in 150 countries and a total revenue of 4.7 billion euros in 2021, Servier employs 21,800 people worldwide.
Kinnate Biopharma Inc. is focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically-defined cancers.
Elevation Oncology is founded on the belief that every patient with cancer deserves to know what is driving the growth of their disease and have access to therapeutics that can stop it.
"Jazz Pharmaceuticals plc (Nasdaq: JAZZ), is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families.
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines. Our Purpose is to push the boundaries of science to deliver life-changing medicines.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.